🇺🇸 FDA
Patent

US 11623927

Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules

granted A61PA61P25/00A61P25/28

Quick answer

US patent 11623927 (Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules) held by The Regents of the University of California expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/00, A61P25/28, A61P35/00